You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-1535

Showing 1 - 25 of 5,042
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)

Not yet recruiting
  • Asthma
  • Beclomethasone Dipropionate/Formoterol Fumarate
  • Beclomethasone Dipropionate
  • (no location specified)
Mar 14, 2022

Asthma Trial in Pisa (CHF1535 200/6 µg, BDP 100 µg)

Completed
  • Asthma
  • CHF1535 200/6 µg
  • BDP 100 µg
  • Pisa, Italy
    Cardio-Thoracic and Vascular Dept, University of Pisa
Oct 28, 2021

High Grade Glioma Trial in Phoenix (BDTX-1535)

Not yet recruiting
  • High Grade Glioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Oct 2, 2023

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Breast Cancer, Breast Tumor, Breast Cancer Stage IV Trial in San Juan (MBQ-167)

Recruiting
  • Breast Cancer
  • +2 more
  • San Juan, Puerto Rico
    FDI Clinical Research
Oct 4, 2023

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Patient Decision Aid, Treatment As Usual Trial in Heidelberg, Dresden (Patient Decision Aid)

Completed
  • Patient Decision Aid
  • Treatment As Usual
  • Patient Decision Aid
  • Heidelberg, Baden-Württemberg, Germany
  • +1 more
Nov 2, 2022

Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)

Active, not recruiting
  • Mesenchymal Chondrosarcoma
  • Prato, Firenze, Italy
  • +5 more
Oct 29, 2021

Traumatic Brain Injury, Intracranial Hypertension Trial in London (nICP)

Completed
  • Traumatic Brain Injury
  • Intracranial Hypertension
  • nICP
  • London, England, United Kingdom
    Royal London Hospital
Nov 18, 2022

Blocking TNF to Potentiate ICI-dependent Immune Awakening in

Recruiting
  • Melanoma
  • +2 more
    • Toulouse, France
      Institut Claudius Regaud
    May 25, 2023

    Asthma in Children Trial in Copenhagen, (free comb. beclomethasone DPI and formoterol DPI, CHF 1535 50/6 NEXT DPI)

    Completed
    • Asthma in Children
    • free comb. beclomethasone DPI and formoterol DPI
    • CHF 1535 50/6 NEXT DPI
    • Copenhagen,, Denmark
      BørneAstmaKlinikken, Hans Knudsens Plads 1A,
    Jul 30, 2020

    COPD Trial in Paris (Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI, Budesonide 200 µg plus formoterol 6 µg DPI,

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
    • +2 more
    • Paris, France
      Thomas Similowski
    Oct 28, 2021

    Asthma Trial in Copenhagen (CHF1535 pMDI + AC Plus, BDP + AC Plus, Formoterol + AC Plus)

    Completed
    • Asthma
    • CHF1535 pMDI + AC Plus
    • +2 more
    • Copenhagen, Denmark
      BorneAstmaKlinikken
    Jul 30, 2020

    Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)

    Not yet recruiting
    • Brain Metastases
    • Brain Cancer
    • Miami, Florida
      Miami Cancer Institute at Baptist Health South Florida
    Jan 3, 2023

    Pancreatic Cancer Stage IV Trial in United States (CBP501 (16), CBP501 (25), Cisplatin)

    Active, not recruiting
    • Pancreatic Cancer Stage IV
    • CBP501 (16)
    • +3 more
    • Tucson, Arizona
    • +19 more
    Aug 16, 2022

    Asthma Trial in Copenhagen, Manchester (CHF1535 NEXT DPI, BDP DPI and formoterol DPI)

    Completed
    • Asthma
    • CHF1535 NEXT DPI
    • BDP DPI and formoterol DPI
    • Copenhagen, Denmark
    • +1 more
    Jul 30, 2020

    COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)

    Completed
    • COPD
    • CHF 1535 NEXThaler 800/48
    • +4 more
    • Manchester, United Kingdom
      Medicine Evaluation Unit
    Oct 28, 2021

    Generalized Convulsive Status Epilepticus Trial in Sohag (Ketamine, Midazolam, Placebo)

    Recruiting
    • Generalized Convulsive Status Epilepticus
    • Sohag, Egypt
      Sohag University Hospital
    Mar 21, 2023

    Status Epilepticus, Generalized Convulsive Status Epilepticus, Status Epilepticus, Generalized Trial in Sohag (Levetiracetam,

    Completed
    • Status Epilepticus
    • +3 more
    • Sohag, Egypt
      Department of Pediatrics - Sohag University Hospital
    Sep 17, 2022

    Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

    Terminated
    • Cervical Cancer
    • +3 more
    • Cabozantinib 40 MG oral once a day
    • Pembrolizumab 200 mg IV every 3 weeks
    • Mobile, Alabama
      University of South Alabama Mitchell Cancer Institute
    Jun 3, 2022

    Patient Undergoing Surgery Trial in Istanbul (aromatherapy, Placebo)

    Completed
    • Patient Undergoing Surgery
    • aromatherapy
    • Placebo
    • Istanbul, Turkey
      Çağla
    Jan 19, 2023

    COPD Trial in Sofia (CHF 5993 DPI, CHF5993 pMDI, CHF 1535 pMDI)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • CHF 5993 DPI
    • +4 more
    • Sofia, Bulgaria
      Medical Center Convex EOOD
    Apr 8, 2021

    P0.1 and Extubation Failure in Critically Ill Patients

    Not yet recruiting
    • Weaning Failure
    • +2 more
    • Reintubation
    • Amiens, France
    • +2 more
    Mar 25, 2023

    Cardiovascular Disease, Diabetes, Type 2 Trial in Milwaukee (Goodbelly first, Placebo first)

    Recruiting
    • Cardiovascular Disease
    • Diabetes Mellitus, Type 2
    • Goodbelly first
    • Placebo first
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Dec 13, 2022

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023